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Purpose: Mechanical load is one of the most important factors of bone
metabolism and disuse atrophy is consequent of loss of the loading. Pa-
tients of progressed osteoarthritis (OA) of the knee are hindered standing,
walking and other daily activities because of severe knee pain. We tested
whether there was difference in the values of bone mineral density (BMD)
of the femoral neck between suffered limb and non-suffered limb, BMD
value of the femoral neck in patients of the progressed OA of the knee
was more decreased compared with age matched group, the value of
BMD in the femoral neck of the patients was smaller than that value in
the lumbar vertebras, and total knee arthroplasty (TKA) for the patient
improved BMD values of the femoral neck or the lumbar vertebras.
Methods: We took 47 patients, who suffered from progressed knee OA
or idiopathic necrosis of the knee and were operated TKA since February
2007to April 2008, as objects of study. 18 patients were followed for
6 months after TKA and 7 patients were followed for 1 year. Mann-
Whitney’s U-test was performed as statistic analysis using Statistic Excel
2006.
Results: All patients have progressed the knee pain and activity of
daily life. The value of BMD in the femoral neck of the suffered limb
was 74.7±10.51 percent of young adult mean (%YAM) and the value
in the non-suffered limb was 71.8±14.89%YAM. The value of BMD in
the Ward’s triangle of the suffered limb was 51.1±13.62%YAM and the
value in the non-suffered limb was 46.3±15.10%YAM. The BMD value
in the total proximal portion of the femur (total PF) of the suffered
limb was 84.2±11.46 percent of young adult mean (%YAM) and the
value in the non-suffered limb was 77.6±15.15%YAM. There were not
signiﬁcant differences in those values between suffered and non-suffered
limbs. BMD value in the lumbar vertebras (L2-L4) of the patients was
119.7±26.86 percent of age matched group (%AM), and the value in
the femoral neck was 100.5±16.03%YAM. The BMD value in the femoral
neck of the patients was signiﬁcant smaller than the value in the lumbar
vertebra of them. The values of BMD of 18 patients followed 6 months
was 69.5±13.48%YAM in the femoral neck, 45.8±16.06%YAM in Ward’s
triangle, and 77.1±16.18 in total PF just before operation and the values
were 69.5±12.35%YAM in the neck, 43.8±15.41%YAM in Ward’s triangle,
and 74.0±15.93%YAM in total PF 6 months after operation. The values
of BMD of 7 patients followed 1 year was 62.8±9.59%YAM in the femoral
neck, 42.0±10.09%YAM in Ward’s triangle, and 68.12±12.47 in total
PF just before operation and the values were 59.8±7.58%YAM in the
neck, 31.14±6.59%YAM in Ward’s triangle, and 62.8±12.64%YAM in
total PF 1 year after operation. The BMD value in Ward’s triangle had
decreased signiﬁcantly since operation by 1 year after. The values of
BMD in lumbar vertebras of 18 patients was 84.4±17.92%YAM just before
operation and 83.1±17.67%YAM 6 months after operation. The BMD
value in lumbar vertebras of 7 patients was 79.4±15.60%YAM just before
operation and 78.1±14.88%YAM 1 year after operation. There were no
signiﬁcant differences between those values.
Conclusions: In patients of severe knee OA, the BMD value of the
femoral neck of the suffered limb was not smaller than that in the non-
suffered limb, but the value of the femoral neck was smaller than the value
of lumbar vertebras in same patients, and the values of Ward’s triangle
have decreased since TKA.
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303 AGE AND WALKING IMPAIRMENT AMONG PERSONS
WITH KNEE PAIN AND CORONARY HEART DISEASE: A
POPULATION-BASED STUDY
S. Morewitz. San Jose State University, San Jose, CA, USA
Purpose: Studies have found that both age and physical activity are risk
factors for knee osteoarthritis. These factors also can increase the level
of disability associated with osteoarthritis. However, little is known about
the effects of coronary heart diseases and other co-morbid conditions on
disability levels for older persons with osteoarthritis. As individuals with
both osteoarthritis and coronary heart disease get older, they may have
an increased risk for pain and disability compared to older adults without
these co-morbid diseases or with only one of these conditions.
Methods: The following study tests the null hypothesis that age is not
associated with impairment in walking among individuals with knee pain
and coronary heart disease, after adjusting for other possible predictor
variables, such as gender, race/ethnicity, marital status, and household
income. The ﬁndings from the population-based 1998 National Health
Interview Survey (N=30,534 adults) were used. Descriptive and correla-
tional procedures evaluated the association between age and difﬁculty
walking 14 mile without special equipment among persons with and
without knee pain and coronary heart disease.
Results: The null hypothesis was partly rejected. Age was associated
with difﬁculty walking 14 mile without special equipment among persons
with knee pain but without coronary heart disease (r = +0.325, N=4,009,
p< 0.000). However, there was no association between age and walking
impairment among individuals with both knee pain and coronary heart
disease. Individuals in this latter category may be too impaired because of
their two co-morbid conditions to walk 14 mile without special equipment.
These results remained statistically signiﬁcant after adjusting for possible
predictor variables.
Conclusions: These ﬁndings highlight the need to screen for and ag-
gressively manage walking impairment in older adults, especially in older
persons with knee pain and coronary heart disease.
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Purpose: Osteoarthritis (OA) is usually a slowly progressive disease.
With longer disease duration, quality of life (QOL) declines, but the loss
in QOL over time due to OA duration in those with pre-existing disease
has not been well quantiﬁed. The purpose of this study is to quantify the
further decline in QOL due to increasing duration of knee or hip OA in
those with pre-existing disease.
Methods: In 2007, information was collected from 1338 residents
19 years or older of British Columbia, Canada with knee or hip OA. The
inclusion criterion was at least two medical visits for OA or one hospitaliza-
tion within a 365-day period, or hip or knee replacement surgery, between
1992 and 2006. Disability was evaluated by: (a) the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC) pain (WP), stiffness
(WS), function (WF) and aggregate (WG) scales, normalized to 0–100
with 100 best; and (b) the Short Form 8 physical (PSF8) and mental
(MSF8) scales standardized to 50/10 on the 2000 US Census.
OA disease duration (OAD) had 4 levels: <1 year, 1−5 years, 6−10 years
and 11+ years. Health outcomes were regressed on OAD, adjusting for
age, gender, body mass index, education and comorbidity (an index
counting physical and mental conditions such as cancer, depression,
diabetes and others). Adjusted least squares means (LS-means) were
compared between OAD levels, with conﬁdence intervals for differences
Bonferroni adjusted for multiple comparisons.
Results: Figure 1 shows the LS-means with 95% conﬁdence intervals.
For all outcomes except MSF8, QOL is lowest in those with newly
diagnosed OA (<1 year duration). Despite the relatively small size of
this group, some differences are signiﬁcant before adjustment for mul-
tiple comparisons. However, after adjustment for multiple comparisons
differences with this group are insigniﬁcant. For WP, WF, WG and PSF8,
QOL at 11+ years is signiﬁcantly below the two middle durations, while
the two middle durations are not statistically different from each other. For
WS, the only signiﬁcant difference is that 11+ years is below 1−5 years.
For MSF8, no difference is signiﬁcant.
On the WG scale, the change in QOL from <1 year to 1−5 years OA
duration is 4.27 (95%CI = −6.25, 14.79), the change from 1−5 years
to 6−10 years is −1.28 (95%CI = −5.44, 2.88), and the change from
6−10 years to 11+ years is −4.44 (95%CI = −8.38, −0.50). On the PSF8
scale, the change in QOL from <1 year to 1−5 years duration is 2.57
(95%CI = −2.00, 7.15), the change from 1−5 years to 6−10 years is
